Newsfeeds - Spark Newswire

6 minute read

Provention Bio’s Second Try, Apellis’s Eye Disorder Drug Review, 3 Adcom Verdicts And More: November’s Key PDUFA Catalysts Biotech Investors Must Know

Today, 2:48 AM

Editor's note: This story has been corrected to reflect that the FDA deferred action on Amicus Therapeutics' Biologics License Application.

APLS

3 minute read

Nasdaq Down 60 Points; Eli Lilly Lowers Earnings Forecast

By Lisa Levin

Today, 2:48 AM

U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 50 points on Tuesday.

ABMD

1 minute read

Eli Lilly Sees FY22 Adj EPS Of $7.70-$7.85 Vs. Prior Range Of $7.90-$8.05 And $8.08 Consensus

By Benzinga Newsdesk

Today, 2:48 AM

The company forecasts FY22 sales of $28.5 billion-$29.0 billion compared to previous guidance of $28.8-$29.3 billion and a consensus of $28.27 billion

LLY

1 minute read

Eli Lilly Q3 EPS $1.98 Beats $1.92 Estimate, Sales $6.94B Beat $6.91B Estimate

By Benzinga Newsdesk

Today, 2:48 AM

Eli Lilly (NYSE:LLY) reported quarterly earnings of $1.98 per share which beat the analyst consensus estimate of $1.92 by 3.13 percent. This is a 11.86 percent increase over earnings of $1.77 per share from the same

LLY

1 minute read

Investor Optimism Drops Slightly Despite Dow Recording Best Month Since 1976

By Lisa Levin

Today, 2:48 AM

The CNN Money Fear and Greed index showed some easing in overall market sentiment after US stocks recorded losses on Monday. The Dow Jones, however, notched its best month since 1976, with all the major indices ending a two-month losing streak.

AMD

1 minute read

Pfizer, Eli Lilly And 3 Stocks To Watch Heading Into Tuesday

By Lisa Levin

Today, 2:48 AM

With US stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

AMD

2 minute read

After FDA, European Agency Limits Use Of Certain JAK Inhibitors Amid Safety Concerns

By Vandana Singh

Today, 2:48 AM

The European Medicine Agency’s safety committee recommended that a group of JAK inhibitors for chronic inflammatory disorders be only used…

ABBV

1 minute read

Verzenio Receives Positive Reimbursement Recommendation From Canadian Agency For Drugs And Technologies In Health For Early Breast Cancer

By Benzinga Newsdesk

Today, 2:48 AM

- Reuters

LLY

4 minute read

News

Lilly Commits $92.5M To Purdue To Establish An Innovative Pharmaceutical Manufacturing Scholarship Program And To Extend Research Collaboration

By Benzinga Newsdesk

Today, 2:48 AM

Scholarships will prioritize students from underrepresented groups, who have overcome disadvantages or are first generation to attend college Research collaboration aims to develop new methods for delivering therapies

LLY

4 minute read

Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights

Today, 2:48 AM

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

ABBV